Chlorotrianisene
- Generic Name
- Chlorotrianisene
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H21ClO3
- CAS Number
- 569-57-3
- Unique Ingredient Identifier
- 6V5034L121
- Background
A powerful synthetic, non-steroidal estrogen. [PubChem]
- Indication
Used to treat symptoms of menopause, deficiencies in ovary function (including underdevelopment of female sexual characteristics and some types of infertility), and in rare cases, prostate cancer. Chlorotrianisene may also be used to prevent breast engorgement following childbirth.
- Associated Conditions
- -
- Associated Therapies
- -
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
- First Posted Date
- 2007-12-18
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- University of Pittsburgh
- Target Recruit Count
- 19
- Registration Number
- NCT00576056
- Locations
- 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath